Nalaganje...
Fludarabine, Cyclophosphamide, Mitoxantrone plus Rituximab (FCM-R) in Frontline CLL < 70 Years
Randomized trials demonstrated the superiority of chemoimmunotherapy over chemotherapy in the frontline treatment of CLL. Based on favorable experience with the addition of mitoxantrone (M) to fludarabine (F) plus cyclophosphamide (C), we designed a pilot study testing the combination of FCM plus ri...
Shranjeno v:
| izdano v: | Leuk Res |
|---|---|
| Main Authors: | , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2009
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4845644/ https://ncbi.nlm.nih.gov/pubmed/19646755 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.leukres.2009.07.008 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|